Trials / Unknown
UnknownNCT06180239
Segmentectomy vs Lobectomy
Different Segmentectomy vs Lobectomy Comparison in NSCLC
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Actual indications for stage Ia NSCLC patients suggest lobectomy and lymphadenectomy. On the other hand, recent studies reported non-inferiority of segmentectomy in case of nodule \< 2cm or with ground glass appearance at computed tomography. However, most of these studies did not report specifical analysis on kind of segmentectomy (single or multiple) and kind of lobectomy. Moreover, a specific study on solid nodules only is still missing. For these reasons, the effectiveness of segmentectomy instead lobectomy for every kind of segment or tumor is still to be defined. Aim of this study is to analyze survival outcome in patients underwent single or multiple segmentectomy compared to lobectomy in stage I non small cell lung cancer.
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2022-12-31
- Completion
- 2024-12-31
- First posted
- 2023-12-22
- Last updated
- 2023-12-22
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06180239. Inclusion in this directory is not an endorsement.